Research map: Mucosal IgG Interacts with Herpes Simplex Virus Glycoprotein E, an Fcγ Receptor Mimetic, and Neutralizes Viral Infection: Activity is Reduced in the Setting of Vaginal Dysbiosis

Back to the article

Papers in this map

  1. Fcγ receptors as regulators of immune responses · Falk Nimmerjahn · 2007 · 2976 citations · Cited by this paper
  2. Comparative Evaluation of E6/E7 mRNA Expression and Viral DNA Load in Cervical Lesions With Multiple High-Risk Human Papillomavirus Infection · 2026 · Related
  3. Characterization of Herpes Simplex Virus Strains Differing in their Effects on Social Behaviour of Infected Cells · P. M. Ejercito · 1968 · 881 citations · Cited by this paper
  4. Diverse Genetic Lineages Spreading Across Healthcare and Community Boundaries Underlie Extended-Spectrum Cephalosporin-Resistant Enterobacterales Colonization Burden in Botswana · 2026 · Related
  5. IgA Fc Receptors · Renato C. Monteiro · 2003 · 539 citations · Cited by this paper
  6. Repeated Influenza Vaccination in Children: Effect Scale, Timing, and Causal Interpretation · 2026 · Related
  7. Global Estimates of Prevalent and Incident Herpes Simplex Virus Type 2 Infections in 2012 · Katharine Jane Looker · 2015 · 535 citations · Cited by this paper
  8. Influenza Attack Rates and Vaccine Effectiveness by Prior-Season Infection and Vaccination: A 17-Season Analysis · 2026 · Related
  9. Association between Acquisition of Herpes Simplex Virus Type 2 in Women and Bacterial Vaginosis · Thomas L. Cherpes · 2003 · 423 citations · Cited by this paper
  10. Characterization of hepatitis B virus in blood donors who were disqualified based on testing: genotype distribution, infectivity, and replicative fitness in human hepatocytes · 2026 · Related
  11. Rethinking mucosal antibody responses: IgM, IgG and IgD join IgA · Kang Chen · 2020 · 353 citations · Cited by this paper
  12. Safety, Tolerability, and Immunogenicity of Revaccination With mRNA-1345 RSV Vaccine Administered 24 Months Following a Primary Dose in Adults ≥60 Years of Age · 2026 · Related
  13. Genital Herpes Has Played a More Important Role than Any Other Sexually Transmitted Infection in Driving HIV Prevalence in Africa · Laith Jamal Abu-Raddad · 2008 · 260 citations · Cited by this paper
  14. Shortening HCV Treatment in US Jails: Opportunities and Implementation Considerations · 2026 · Related
  15. Structure of FcγRI in complex with Fc reveals the importance of glycan recognition for high-affinity IgG binding · Jinghua Lu · 2015 · 153 citations · Cited by this paper
  16. Neutralization Capacity Against SARS-CoV-2 Ancestral, Delta, and Omicron Variants Before and After Heterologous Booster Vaccination in Fijian Healthcare Workers · 2026 · Related
  17. Evidence for Innate Immune System Activation in HIV Type 1–Infected Elite Controllers · Sonya Krishnan · 2013 · 148 citations · Cited by this paper
  18. Watching the Ship, Missing the Forest: Why Ecological Spillover, Reservoir Ecology, and Environmental Change Remain the True Hantavirus Threats in North America · 2026 · Related
  19. Genital Tract Shedding of Herpes Simplex Virus Type 2 in Women: Effects of Hormonal Contraception, Bacterial Vaginosis, and Vaginal Group B Streptococcus Colonization · Thomas L. Cherpes · 2005 · 144 citations · Cited by this paper
  20. Sampling and Host–Strain Interactions Shape Detection of Staphylococcus aureus Transmission in Hospitals · 2026 · Related
  21. The global roadmap for advancing development of vaccines against sexually transmitted infections: Update and next steps · Sami L. Gottlieb · 2016 · 142 citations · Cited by this paper
  22. Impact of Glycosylation on Effector Functions of Therapeutic IgG · Riad Abès · 2010 · 134 citations · Cited by this paper
  23. Synergistic Copathogens — HIV-1 and HSV-2 · Lawrence Corey · 2007 · 117 citations · Cited by this paper
  24. IgG in cervicovaginal mucus traps HSV and prevents vaginal Herpes infections · Y-Y Wang · 2014 · 116 citations · Cited by this paper
  25. The global and regional burden of genital ulcer disease due to herpes simplex virus: a natural history modelling study · Katharine Jane Looker · 2020 · 102 citations · Cited by this paper
  26. PRO 2000 Gel Inhibits HIV and Herpes Simplex Virus Infection Following Vaginal Application: A Double‐Blind Placebo‐Controlled Trial · Marla J. Keller · 2005 · 94 citations · Cited by this paper
  27. Cervicovaginal Secretions Contribute to Innate Resistance to Herpes Simplex Virus Infection · Minnie John · 2005 · 87 citations · Cited by this paper
  28. Impairment of the Mucosal Immune System: IgA and IgM Cleavage Detected in Vaginal Washings of a Subgroup of Patients with Bacterial Vaginosis · Sabina Cauci · 1998 · 84 citations · Cited by this paper
  29. The Herpes Simplex Virus 1 IgG Fc Receptor Blocks Antibody-Mediated Complement Activation and Antibody-Dependent Cellular Cytotoxicity In Vivo · John M. Lubinski · 2011 · 84 citations · Cited by this paper
  30. A Randomized Trial to Assess Anti-HIV Activity in Female Genital Tract Secretions and Soluble Mucosal Immunity Following Application of 1% Tenofovir Gel · Marla J. Keller · 2011 · 83 citations · Cited by this paper
  31. The Roles of Host and Viral Antibody Fc Receptors in Herpes Simplex Virus (HSV) and Human Cytomegalovirus (HCMV) Infections and Immunity · Jennifer Anne Jenks · 2019 · 76 citations · Cited by this paper
  32. HSV-2 ΔgD elicits FcγR-effector antibodies that protect against clinical isolates · Christopher D. Petro · 2016 · 75 citations · Cited by this paper
  33. ORIGINAL ARTICLE: Female Genital Tract Secretions Inhibit Herpes Simplex Virus Infection: Correlation with Soluble Mucosal Immune Mediators and Impact of Hormonal Contraception · Gail F. Shust · 2009 · 73 citations · Cited by this paper
  34. Blocking Herpes Simplex Virus 2 Glycoprotein E Immune Evasion as an Approach To Enhance Efficacy of a Trivalent Subunit Antigen Vaccine for Genital Herpes · Sita Awasthi · 2014 · 67 citations · Cited by this paper
  35. Postcoital Bioavailability and Antiviral Activity of 0.5% PRO 2000 Gel: Implications for Future Microbicide Clinical Trials · Marla J. Keller · 2010 · 63 citations · Cited by this paper
  36. Neonatal Herpes Simplex Virus Disease · Nicole L. Samies · 2021 · 62 citations · Cited by this paper
  37. Comparison of Mucosal Markers of Human Immunodeficiency Virus Susceptibility in Healthy Premenopausal Versus Postmenopausal Women · Andrea Ries Thurman · 2017 · 52 citations · Cited by this paper
  38. Altered Biomarkers of Mucosal Immunity and Reduced Vaginal Lactobacillus Concentrations in Sexually Active Female Adolescents · Rebecca Pellett Madan · 2012 · 41 citations · Cited by this paper
  39. A non-neutralizing glycoprotein B monoclonal antibody protects against herpes simplex virus disease in mice · Masayuki Kuraoka · 2022 · 38 citations · Cited by this paper

Source: OpenAlex (CC0)